コレステロール検査市場の2030年までの予測：製品タイプ、検査タイプ、流通チャネル、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界のコレステロール検査市場は2023年に68億4,000万米ドルを占め、予測期間中のCAGRは10.3％で成長し、2030年には135億米ドルに達する見込みです。

コレステロール検査は、血液中のコレステロールレベルを測定することを目的とした診断手順です。低比重リポタンパク質（LDL）、高比重リポタンパク質（HDL）、トリグリセリドを含む様々な種類のコレステロールを評価し、心血管の健康状態を評価するために不可欠です。通常、コレステロール検査は血液を採取して行われ、心臓病を発症したり心血管イベントを経験したりするリスクのある人を特定するのに役立ちます。

世界保健機関（WHO）によると、2022年には6億5,000万人以上の成人が肥満です。

心血管疾患の有病率の上昇

心臓発作や脳卒中を含む心血管疾患は、世界的に罹患率および死亡率の主要な原因となっています。高コレステロール値は、これらの疾患の主要な危険因子です。心血管疾患の有病率が上昇し続けているため、コレステロール検査の必要性が高まっています。コレステロール検査は、低比重リポタンパク質（LDL）コレステロール、高比重リポタンパク質（HDL）コレステロール、トリグリセリドなど、さまざまなコレステロール成分のレベルを評価するのに役立ちます。全体として、心血管疾患の有病率が上昇していることが、市場の需要を促進する要因となっています。

高コスト

検査室での検査、診断機器、専門家の費用など、コレステロール検査に関連する高額なコストは、特に十分な保険が適用されない人やヘルスケア・サービスを利用できない人にとって、経済的な障壁となる可能性があります。さらに、ヘルスケア・プロバイダーは、手頃な価格の検査オプションを提供する必要性と、収益性を維持し運営経費を賄うことのバランスをとるという課題に直面しています。その結果、高コストがコレステロール検査市場にとって大きな脅威となっています。

技術の進歩

新規バイオマーカーとマルチプレックス検査プラットフォームの統合により、包括的な脂質プロファイリングが可能になり、従来のコレステロール測定にとどまらず、心血管リスク因子をより総合的に評価できるようになった。さらに、検査室ベースのコレステロール検査技術の進歩により、自動分析装置や高スループット・システムのイントロダクションが導入され、検査の効率性と拡張性が向上するとともに、人的エラーや運用コストが削減されています。

限られた認識

心臓病や脳卒中のリスクを評価する上でコレステロール検査が重要であることを知らない人が多く、特に無症状の人の検査率が低いです。さらに、コレステロール検査の手順に関する誤解や誤った情報、侵襲性の認識、採血に伴う不快感などが、検査を受けようとしない人をさらに遠ざける可能性があります。したがって、認知度の低さが市場拡大を制限する大きな要因となっています。

COVID-19の影響

COVID-19の流行はコレステロール検査市場にマイナスの影響を与えました。当初、ヘルスケア・システムの焦点は危機管理にシフトし、コレステロール検査や予防医療を含む日常的な医療サービスの中断につながった。急を要しない医療予約の多くが延期またはキャンセルされ、その結果コレステロール検査が減少しました。さらに、ウイルス感染の懸念から、どうしても必要な場合以外はヘルスケア施設を避けるようになり、コレステロール検査を受ける人の数はさらに減少しました。

予測期間中、検査キット・セグメントが最大となる見込み

検査キット・セグメントが最大のシェアを占めると推定されます。これらのキットには通常、従来の検査室以外でコレステロール検査を実施するために必要なコンポーネントがすべて含まれています。多くの場合、検査ストリップ、採血用ランセット、分析に必要な溶液や試薬が含まれています。ヘルスケア・プロバイダーはまた、患者の診察や健康診断の際に迅速な評価を行うためにコレステロール検査キットを利用しています。さらに、これらのキットは迅速な結果を提供するため、タイムリーな介入や治療の決定を可能にします。

予測期間中、総コレステロール検査分野が最も高いCAGRが見込まれる

総コレステロール検査分野は、予測期間中に有利な成長が見込まれます。この検査では、高比重リポ蛋白（HDL）コレステロールと低比重リポ蛋白（LDL）コレステロールの両方、およびトリグリセリドを含む、血液中に存在するコレステロールの総量を測定します。総コレステロール検査は、予防ヘルスケアにおいて重要な役割を果たし、個人の脂質プロファイルと全体的な心血管系の健康状態に関する貴重な洞察を提供します。

最大のシェアを占める地域

北米は、強固なヘルスケア・インフラ、高度な診断技術、心血管疾患リスク因子の高い有病率により、予測期間中に最大の市場シェアを占めました。同地域には、革新的なコレステロール低下薬や診断技術の開発に取り組む製薬企業やバイオテクノロジー企業が数多く存在し、市場の成長と技術革新を促進しています。さらに、公衆衛生キャンペーンや教育活動により、コレステロール管理や健康的なライフスタイルの選択の重要性に対する認識が高まり、コレステロール検査サービスや製品に対する需要がさらに高まっています。

CAGRが最も高い地域：

アジア太平洋地域は、予測期間中に収益性の高い成長を遂げると予想されます。アジア太平洋地域の国々は、高齢化や可処分所得の高い中流階級の出現などの人口動態の変化を経験しており、コレステロール検査を含むヘルスケア・サービスへの需要を促進しています。さらに、心血管系の健康促進や疾病予防プログラムなど、非感染性疾患への対処を目的とした政府の取り組みが、この地域の市場成長をさらに促進しています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のコレステロール検査市場：製品タイプ別

• 検査ストリップ
• 検査キット
• 検査メーター
• その他の製品タイプ

第6章 世界のコレステロール検査市場：検査タイプ別

• 高密度リポタンパク質（HDL）コレステロール
• 低密度リポタンパク質（LDL）コレステロール
• 総コレステロール検査
• 中性脂肪/VLDLコレステロール検査
• その他の検査タイプ

第7章 世界のコレステロール検査市場：流通チャネル別

• 店頭
• 処方箋ベース

第8章 世界のコレステロール検査市場：エンドユーザー別

• 在宅ケア
• 病院とクリニック
• 診断センター
• その他のエンドユーザー

第9章 世界のコレステロール検査市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Thermo Fisher Scientific
• Cell Biolabs, Inc.
• Randox Laboratories Ltd.
• Clinical Reference Laboratory, Inc.
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Alere Inc.
• PTS Diagnostics
• Eurofins Scientific
• F. Hoffmann-La Roche AG
• Horiba Ltd
• Danaher Corp
• Abbott Laboratories
• Nova Biomedical

List of Tables

• Table 1 Global Cholesterol Test Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
• Table 3 Global Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
• Table 4 Global Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
• Table 5 Global Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
• Table 6 Global Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 7 Global Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
• Table 8 Global Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
• Table 9 Global Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
• Table 10 Global Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
• Table 11 Global Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
• Table 12 Global Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 13 Global Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 14 Global Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
• Table 15 Global Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
• Table 16 Global Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
• Table 17 Global Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
• Table 18 Global Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 19 Global Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 20 Global Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 21 North America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
• Table 22 North America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
• Table 23 North America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
• Table 24 North America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
• Table 25 North America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
• Table 26 North America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 27 North America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
• Table 28 North America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
• Table 29 North America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
• Table 30 North America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
• Table 31 North America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
• Table 32 North America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 33 North America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 34 North America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
• Table 35 North America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
• Table 36 North America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
• Table 37 North America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
• Table 38 North America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 39 North America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 40 North America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 41 Europe Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
• Table 42 Europe Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
• Table 43 Europe Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
• Table 44 Europe Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
• Table 45 Europe Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
• Table 46 Europe Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 47 Europe Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
• Table 48 Europe Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
• Table 49 Europe Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
• Table 50 Europe Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
• Table 51 Europe Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
• Table 52 Europe Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 53 Europe Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 54 Europe Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
• Table 55 Europe Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
• Table 56 Europe Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
• Table 57 Europe Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
• Table 58 Europe Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 59 Europe Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 60 Europe Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 61 Asia Pacific Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Asia Pacific Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
• Table 63 Asia Pacific Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
• Table 64 Asia Pacific Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
• Table 65 Asia Pacific Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
• Table 66 Asia Pacific Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 67 Asia Pacific Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
• Table 68 Asia Pacific Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
• Table 69 Asia Pacific Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
• Table 70 Asia Pacific Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
• Table 71 Asia Pacific Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
• Table 72 Asia Pacific Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 73 Asia Pacific Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 74 Asia Pacific Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
• Table 75 Asia Pacific Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
• Table 76 Asia Pacific Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
• Table 77 Asia Pacific Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
• Table 78 Asia Pacific Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 79 Asia Pacific Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 80 Asia Pacific Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 81 South America Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
• Table 82 South America Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
• Table 83 South America Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
• Table 84 South America Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
• Table 85 South America Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
• Table 86 South America Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 87 South America Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
• Table 88 South America Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
• Table 89 South America Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
• Table 90 South America Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
• Table 91 South America Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
• Table 92 South America Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 93 South America Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 94 South America Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
• Table 95 South America Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
• Table 96 South America Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
• Table 97 South America Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
• Table 98 South America Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 99 South America Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 100 South America Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 101 Middle East & Africa Cholesterol Test Market Outlook, By Country (2021-2030) ($MN)
• Table 102 Middle East & Africa Cholesterol Test Market Outlook, By Product Type (2021-2030) ($MN)
• Table 103 Middle East & Africa Cholesterol Test Market Outlook, By Test Strips (2021-2030) ($MN)
• Table 104 Middle East & Africa Cholesterol Test Market Outlook, By Test Kits (2021-2030) ($MN)
• Table 105 Middle East & Africa Cholesterol Test Market Outlook, By Test Meters (2021-2030) ($MN)
• Table 106 Middle East & Africa Cholesterol Test Market Outlook, By Other Product Types (2021-2030) ($MN)
• Table 107 Middle East & Africa Cholesterol Test Market Outlook, By Test Type (2021-2030) ($MN)
• Table 108 Middle East & Africa Cholesterol Test Market Outlook, By High-Density Lipoprotein (HDL) Cholesterol (2021-2030) ($MN)
• Table 109 Middle East & Africa Cholesterol Test Market Outlook, By Low-Density Lipoprotein (LDL) Cholesterol (2021-2030) ($MN)
• Table 110 Middle East & Africa Cholesterol Test Market Outlook, By Total Cholesterol Test (2021-2030) ($MN)
• Table 111 Middle East & Africa Cholesterol Test Market Outlook, By Triglycerides/VLDL Cholesterol Test (2021-2030) ($MN)
• Table 112 Middle East & Africa Cholesterol Test Market Outlook, By Other Test Types (2021-2030) ($MN)
• Table 113 Middle East & Africa Cholesterol Test Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 114 Middle East & Africa Cholesterol Test Market Outlook, By Over the Counter (2021-2030) ($MN)
• Table 115 Middle East & Africa Cholesterol Test Market Outlook, By Prescription Based (2021-2030) ($MN)
• Table 116 Middle East & Africa Cholesterol Test Market Outlook, By End User (2021-2030) ($MN)
• Table 117 Middle East & Africa Cholesterol Test Market Outlook, By Homecare (2021-2030) ($MN)
• Table 118 Middle East & Africa Cholesterol Test Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
• Table 119 Middle East & Africa Cholesterol Test Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
• Table 120 Middle East & Africa Cholesterol Test Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Cholesterol Test Market is accounted for $6.84 billion in 2023 and is expected to reach $13.5 billion by 2030 growing at a CAGR of 10.3% during the forecast period. A cholesterol test is a diagnostic procedure aimed at measuring the levels of cholesterol in the blood. It assesses various types of cholesterol, including low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides, which are essential for evaluating cardiovascular health. Typically conducted through a blood sample, cholesterol testing helps identify individuals at risk of developing heart disease or experiencing cardiovascular events.

According to the World Health Organization (WHO), in 2022, over 650 million adults were obese.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular diseases

Cardiovascular diseases, including heart attacks and strokes, are leading causes of morbidity and mortality globally. High cholesterol levels are a major risk factor for these diseases. As the prevalence of cardiovascular diseases continues to rise, there is a growing need for cholesterol testing. Cholesterol testing helps in assessing the levels of different cholesterol components, such as low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides. Overall, the rising prevalence of cardiovascular diseases is a factor driving market demand.

Restraint:

High cost

The high costs associated with cholesterol testing procedures, including laboratory tests, diagnostic equipment, and professional fees, can create financial barriers for individuals, particularly those without adequate insurance coverage or access to healthcare services. Moreover, healthcare providers face challenges in balancing the need to provide affordable testing options with maintaining profitability and covering operational expenses. As a result, high costs present a significant threat to the cholesterol test market.

Opportunity:

Technological advancements

The integration of novel biomarkers and multiplex testing platforms enables comprehensive lipid profiling, providing a more holistic assessment of cardiovascular risk factors beyond traditional cholesterol measurements. Furthermore, advancements in laboratory-based cholesterol testing technologies have led to the introduction of automated analyzers and high-throughput systems, enhancing testing efficiency and scalability while reducing human error and operational costs.

Threat:

Limited awareness

Many individuals remain unaware of the importance of cholesterol testing in assessing their risk of heart disease and stroke, leading to low testing rates, especially among asymptomatic individuals. Additionally, misconceptions or misinformation about cholesterol testing procedures, perceived invasiveness, or discomfort associated with blood draws may further deter individuals from seeking testing. Therefore, limited awareness is a significant factor limiting market expansion.

Covid-19 Impact

The COVID-19 pandemic had a negative impact on the cholesterol test market. Initially, the focus of healthcare systems shifted towards managing the crisis, leading to disruptions in routine medical services, including cholesterol testing and preventive care. Many non-urgent medical appointments were postponed or cancelled, resulting in a decline in cholesterol screenings. Additionally, concerns about virus transmission prompted individuals to avoid healthcare facilities unless absolutely necessary, further reducing the number of people seeking cholesterol tests.

The test kits segment is expected to be the largest during the forecast period

The test kits segment is estimated to hold the largest share. These kits typically contain all the necessary components for conducting cholesterol tests outside of traditional laboratory settings. They often include test strips, lancets for blood sampling, and solutions or reagents required for analysis. Healthcare providers also rely on cholesterol test kits for rapid assessments during patient consultations or health screenings. Additionally, these kits offer quick results, allowing for timely interventions and treatment decisions.

The total cholesterol test segment is expected to have the highest CAGR during the forecast period

The total cholesterol test segment is anticipated to have lucrative growth during the forecast period. This test measures the total amount of cholesterol present in the blood, including both high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol, along with triglycerides. The total cholesterol test plays a critical role in preventive healthcare, providing valuable insights into an individual's lipid profile and overall cardiovascular health status.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the robust healthcare infrastructure, advanced diagnostic technologies, and a high prevalence of cardiovascular disease risk factors. The region is home to numerous pharmaceutical and biotechnology companies engaged in developing innovative cholesterol-lowering medications and diagnostic technologies, driving market growth and innovation. Additionally, public health campaigns and educational efforts raise awareness about the importance of cholesterol management and healthy lifestyle choices, further driving demand for cholesterol testing services and products.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. Countries in the Asia Pacific region are experiencing demographic shifts, including aging populations and the emergence of a middle-class segment with greater disposable income, driving demand for healthcare services, including cholesterol testing. Additionally, government initiatives aimed at addressing non-communicable diseases, including cardiovascular health promotion and disease prevention programs, further propel market growth in this region.

Key players in the market

Some of the key players in the Cholesterol Test Market include Thermo Fisher Scientific, Cell Biolabs, Inc., Randox Laboratories Ltd., Clinical Reference Laboratory, Inc., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Alere Inc., PTS Diagnostics, Eurofins Scientific, F. Hoffmann-La Roche AG, Horiba Ltd, Danaher Corp, Abbott Laboratories and Nova Biomedical.

Key Developments:

In December 2023, Randox Laboratories Ltd and Transgene entered into a scientific collaboration, with the aim of joining their competences to deliver a novel therapeutic approach to oncology therapies.

In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.

In February 2023, Roche announced that it has expanded its collaboration with Janssen Biotech Inc. (Janssen) to create companion diagnostics for targeted therapies, further strengthening research and innovation activities.

In November 2022, Danaher Corporation, a global science and technology innovator, announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.

Product Types Covered:

• Test Strips
• Test Kits
• Test Meters
• Other Product Types

Test Types Covered:

• High-Density Lipoprotein (HDL) Cholesterol
• Low-Density Lipoprotein (LDL) Cholesterol
• Total Cholesterol Test
• Triglycerides/VLDL Cholesterol Test
• Other Test Types

Distribution Channels Covered:

• Over the Counter
• Prescription Based

End Users Covered:

• Homecare
• Hospitals & Clinics
• Diagnostic Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Cholesterol Test Market, By Product Type

• 5.1 Introduction
• 5.2 Test Strips
• 5.3 Test Kits
• 5.4 Test Meters
• 5.5 Other Product Types

6 Global Cholesterol Test Market, By Test Type

• 6.1 Introduction
• 6.2 High-Density Lipoprotein (HDL) Cholesterol
• 6.3 Low-Density Lipoprotein (LDL) Cholesterol
• 6.4 Total Cholesterol Test
• 6.5 Triglycerides/VLDL Cholesterol Test
• 6.6 Other Test Types

7 Global Cholesterol Test Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Over the Counter
• 7.3 Prescription Based

8 Global Cholesterol Test Market, By End User

• 8.1 Introduction
• 8.2 Homecare
• 8.3 Hospitals & Clinics
• 8.4 Diagnostic Centers
• 8.5 Other End Users

9 Global Cholesterol Test Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Thermo Fisher Scientific
• 11.2 Cell Biolabs, Inc.
• 11.3 Randox Laboratories Ltd.
• 11.4 Clinical Reference Laboratory, Inc.
• 11.5 Quest Diagnostics Incorporated
• 11.6 Laboratory Corporation of America Holdings
• 11.7 Alere Inc.
• 11.8 PTS Diagnostics
• 11.9 Eurofins Scientific
• 11.10 F. Hoffmann-La Roche AG
• 11.11 Horiba Ltd
• 11.12 Danaher Corp
• 11.13 Abbott Laboratories
• 11.14 Nova Biomedical